These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25919150)

  • 21. Foreword.
    Etienne CF
    Vaccine; 2015 May; 33 Suppl 1():A1. PubMed ID: 25919148
    [No Abstract]   [Full Text] [Related]  

  • 22. [Economic aspects of health care in relation to vaccination programs].
    Kuszewski K
    Przegl Epidemiol; 2003; 57 Suppl 1():9-13. PubMed ID: 12920999
    [No Abstract]   [Full Text] [Related]  

  • 23. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
    Kamara L; Milstien JB; Patyna M; Lydon P; Levin A; Brenzel L
    Vaccine; 2008 Dec; 26(51):6717-26. PubMed ID: 18955100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ProVac initiative and evolving decision support.
    Sanderson CF
    Vaccine; 2015 May; 33 Suppl 1():A8-10. PubMed ID: 25919181
    [No Abstract]   [Full Text] [Related]  

  • 25. Gates launches $1bn vaccine initiative to target emerging infectious diseases.
    Gulland A
    BMJ; 2017 Jan; 356():j330. PubMed ID: 28104583
    [No Abstract]   [Full Text] [Related]  

  • 26. Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.
    Sosler S; Kallenberg J; Johnson HL
    Vaccine; 2015 May; 33 Suppl 1():A4-5. PubMed ID: 25919172
    [No Abstract]   [Full Text] [Related]  

  • 27. How should GAVI build on its success?
    Arie S
    BMJ; 2011 Sep; 343():d5182. PubMed ID: 21903688
    [No Abstract]   [Full Text] [Related]  

  • 28. Exaggerating the benefits of the 'decade of vaccines'.
    Light DW
    Health Aff (Millwood); 2011 Oct; 30(10):2026; author's reply 2026-7. PubMed ID: 21976349
    [No Abstract]   [Full Text] [Related]  

  • 29. The drivers of facility-based immunization performance and costs. An application to Moldova.
    Maceira D; Goguadze K; Gotsadze G
    Vaccine; 2015 May; 33 Suppl 1():A72-8. PubMed ID: 25919179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Provinces providing more childhood vaccines.
    Eggertson L
    CMAJ; 2006 Jan; 174(1):20. PubMed ID: 16389226
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
    Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
    Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UNICEF asks donors to give poorer nations longer-term commitment.
    Ahmad K
    Lancet; 2002 Jun; 359(9322):2009. PubMed ID: 12076567
    [No Abstract]   [Full Text] [Related]  

  • 33. Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine.
    Kharbanda EO; Lee GM; Koenigs L;
    J Adolesc Health; 2011 Mar; 48(3):320-1. PubMed ID: 21338909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auctions vs negotiations: a study of price differentials.
    Kjerstad E
    Health Econ; 2005 Dec; 14(12):1239-51. PubMed ID: 15945037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on expanding the evidence base to inform vaccine introduction: Program costing and cost-effectiveness analyses.
    Andrus JK; Walker DG
    Vaccine; 2015 May; 33 Suppl 1():A2-3. PubMed ID: 25919161
    [No Abstract]   [Full Text] [Related]  

  • 37. Gavi sets US$7ยท4 billion replenishment target.
    Usher AD
    Lancet; 2019 Sep; 394(10201):817-818. PubMed ID: 31498088
    [No Abstract]   [Full Text] [Related]  

  • 38. "Urgent global response" needed to vaccinate the world's children.
    Baleta A
    Lancet; 2002 Apr; 359(9315):1414. PubMed ID: 11978352
    [No Abstract]   [Full Text] [Related]  

  • 39. Government financing for health and specific national budget lines: the case of vaccines and immunization.
    Lydon P; Beyai PL; Chaudhri I; Cakmak N; Satoulou A; Dumolard L
    Vaccine; 2008 Dec; 26(51):6727-34. PubMed ID: 18625279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of routine immunization services in Moldova: Findings of a facility-based costing study.
    Goguadze K; Chikovani I; Gaberi C; Maceira D; Uchaneishvili M; Chkhaidze N; Gotsadze G
    Vaccine; 2015 May; 33 Suppl 1():A60-5. PubMed ID: 25919177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.